Siren Biotechnology Alternatives & Competitors

12 companies similar to Siren Biotechnology — Universal AAV immuno-gene therapy for cancer

NBE-Therapeutics AG

Next generation antibody drug conjugates

47 Series C

Basel, Switzerland

Biotechnology Health Care +1

Alterome Therapeutics, Inc

To Life!

43 Series B $231.00M

San Diego, United States

Biopharma Biotechnology +1

Imvax, Inc.

Imvax is a clinical-stage biotechnology company developing personalized, whole tumor-deriv...

24 Unknown $253.70M

Philadelphia, United Stat...

Biotechnology Health and Wellness +1

Teon Therapeutics Inc.

Teon is a clinical company targeting metabolic signaling pathways and pioneering the devel...

7 Series A $37.00M

Redwood City, United Stat...

Biopharma Biotechnology +2

Track all Siren Biotechnology competitors

Get real-time alerts when any of these companies raise funding, hire, or show growth signals.

See how it works

ARTBIO

Channeling Energy. Changing Lives.

74 Series B $245.00M

Cambridge, United States

Biotechnology Health Care +2

ARTIDIS

A clinical stage company developing the first nanotechnology platform for rapid diagnostic...

92 Series A $55.80M

Basel, Switzerland

MILAGEN, INC.

Advancing Health Care Through Diagnostics

3 Series B $4.04M

Health Care

Glycyx

Restoring immune response in cancer: reversing Opioid-Induced Immunodeficiency to enhance...

3 Series A $7.10M

San Francisco, United Sta...

Biopharma Biotechnology +1

Prelude Therapeutics

Precision Oncology, Redefined.

126 Post Ipo Equity $147.00M

Wilmington, United States

Biopharma Biotechnology +2

TREOS BIO

Next generation off-the-shelf peptide cancer vaccines effective in broad patient populatio...

15 Convertible Note $22.00M

London, United Kingdom

Biotechnology Health Care +1

Pathios Therapeutics

Using human genetics to transform cancer outcomes

24 Series B $34.37M

United Kingdom

Biotechnology Health Care +1

Avacta Therapeutics

Expanding the reach of highly potent cancer therapies with the pre|CISION® platform.

44 Post Ipo Equity

London, United Kingdom

Biotechnology Health Care +1

About Siren Biotechnology

Universal AAV immuno-gene therapy for cancer

Services

Development of universal AAV immuno-gene therapy, Combination of AAV gene therapy and cytokine immunotherapy

Target Customers

Cancer patients, Medical professionals, Healthcare providers, Oncologists

Taxonomy

Universal AAV Immuno-Gene Therapy, Cancer Treatment, Gene Therapy, Cytokine Immunotherapy, Tumor Cell Destruction, Anti-tumor Immunity, Immunotherapy, Oncology, Medical Innovation

Frequently Asked Questions

Top alternatives to Siren Biotechnology include NBE-Therapeutics AG, Alterome Therapeutics, Inc, Imvax, Inc., Teon Therapeutics Inc., ARTBIO. These companies serve similar markets and are frequently compared.

Bounce Watch tracks 12 companies similar to Siren Biotechnology based on industry overlap, target customers, and business model.

Universal AAV immuno-gene therapy for cancer

Don't just read about them. Follow them.

BounceWatch watches Siren Biotechnology and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.

See how it works

Explore Related

Siren Biotechnology Profile NBE-Therapeutics AG Alternatives Alterome Therapeutics, Inc Alternatives Imvax, Inc. Alternatives All Companies All Signals Trend Reports

Compiled from the BounceWatch company index. We last looked at Siren Biotechnology on 9 Jun 2026. The 12 companies listed here were last checked between 27 Nov 2025 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.